PA
Perceptive Advisors Portfolio holdings
AUM
$5.06B
1-Year Est. Return
314.02%
This Fund
S&P 500
1 Year Est. Return
+314.02%
AUM
$5.46B
AUM Growth
+$2B
(+58%)
Holding
131
Top Buys
| 1 | +$80.3M | |
| 2 | +$65.6M | |
| 3 | +$61.6M | |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$59M |
| 5 |
Dyne Therapeutics
DYN
|
+$55.6M |
Top Sells
| 1 | +$127M | |
| 2 | +$101M | |
| 3 | +$80M | |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$55.9M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$53.9M |
Sector Composition
| 1 | Healthcare | 99.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Viking Therapeutics
VKTX
$3.43B
| – | – |
-105,597
|
|
||
|
VRNA
127
DELISTED
Verona Pharma
VRNA
| – | – |
-524,088
|
|
||
128
State Street SPDR S&P Biotech ETF
XBI
$7.85B
| – | – |
0
|
|
||
|
TEM
129
Tempus AI
TEM
$8.43B
| – | – |
-85,000
|
|
||
|
TECX
130
Tectonic Therapeutic
TECX
$539M
| – | – |
0
|
|